IT firm Cerner invests in Dx maker Claritas Genomics

Boston Children's Hospital spinoff Claritas Genomics, a genetic diagnostic testing company, attracted an investment from IT specialist Cerner, and the two will collaborate to develop a computing infrastructure designed to smooth the diagnostic process from start to finish. Cerner's Millennium Helix integration software helps to order the genomic sequencing, interpret results and incorporate them into a patient's health record, according to a report from Modern Healthcare. The partnership is another example of a growing trend in which IT and diagnostics companies are joining forces for an integrated approach to product development. "Cerner has long focused on the power of genomics and its impact to clinical processes, and this relationship will help advance the field and define a meaningful narrative in personalized medicine between the realms of research, diagnostics and clinical practice," Cerner Senior Vice President Dick Flanigan said in a statement. More

Suggested Articles

InterVene secured $15 million to validate its catheter-based treatment for correcting failed one-way valves in the veins of the legs.

LabCorp, Philips and Mount Sinai are coming together to develop an AI-driven pathology center of excellence, aimed initially at cancer diagnosis.

The FDA followed through with plans to end its Alternative Summary Reporting program, making 20 years’ worth of device safety data publicly available.